$15.66
-0.09-0.57%
Last update: Nov 9, 9:29 AM
Rallybio Corp
RLYBNASDAQ
The average analyst price target for Rallybio is $71, 354.0% above the current price. Of 7 analysts, 3 rate it Buy and 4 Hold. Targets range from $12 to $120. The latest change came on Apr 15, 2025, when Jones Trading downgraded Rallybio from Buy to Hold.
Price Target Range — 6 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
